Camille Edwards, MD
Assistant Professor
Boston University School of Medicine
Dept of Medicine
Hematology & Medical Oncology

MBBS, University of the West Indies




Dr. Edwards is an Assistant Professor of Medicine at Boston University School of Medicine (BUSM). She maintains a clinical practice in hematology at Boston Medical Center (BMC) with a specific research interest in plasma cell disorders such as systemic immunoglobulin light chain (AL) amyloidosis. She is committed to improving the care of vulnerable patient populations using her translational research platform to address unanswered questions encountered in clinical care. After internal medicine residency, she completed hematology and oncology fellowship at BUSM/BMC, obtaining rigorous training through the comprehensive cancer center and the world-renowned BU Amyloidosis Center. Her current research, a collaboration with the Center for Regenerative Medicine (CReM) and BU Amyloidosis Center, focuses on using novel disease models for hematologic malignancies to study the earliest signs of disease, test treatments and develop the most promising therapeutic agents for clinical trials. She is also an active mentor for students and residents, and has a strong passion for teaching and mentoring trainees.

2020-2021 Boston University: American Society of Hematology Research Training Award
2019 Boston University School of Medicine: Residents’ Teaching Award
2018 Boston University School of Medicine: Fellow Immersion Training in Addiction Medicine Scholarship Award
2017 Amyloidosis Foundation: Junior Researcher Travel Award for the XVIth Annual Symposium


Defining a molecular signature of cardiac tissue dysfunction in systemic immunoglobulin light-chain amyloidosis
07/01/2020 - 04/30/2022 (PI)
American Society of Hematology



M13-494: A Phase 3, Multicenter, Randomized, Open Label Study of Venetoclax and Dexamethasone Compared with Pomalidomide and Dexamethasone in Subjects with t(11;14)-Positive Relapsed or Refractory Multiple Myeloma
10/21/2020 - 10/20/2023 (PI)
AbbVie Inc.


Title


Yr Title Project-Sub Proj Pubs

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis       Copy PMIDs To Clipboard

  1. Edwards CV, Rao N, Bhutani D, Mapara MY, Radhakrishnan J, Shames S, Maurer MS, Leng S, Solomon A, Lentzsch S, Eisenberger A. Phase 1a/b Study of Monoclonal Antibody CAEL-101 (11-1F4) in Patients with AL Amyloidosis. Blood. 2021 Sep 14. PMID: 34521113
     
  2. Edwards CV, Bhutani D, Mapara M, Radhakrishnan J, Shames S, Maurer MS, Leng S, Wall JS, Solomon A, Eisenberger A, Lentzsch S. One year follow up analysis of the phase 1a/b study of chimeric fibril-reactive monoclonal antibody 11-1F4 in patients with AL amyloidosis. Amyloid. 2019; 26(sup1):115-116. PMID: 31343323
     
  3. Nwabudike SM, Edwards CV, Akinboro O, Quinn K, Sarosiek S, Ko N. Cyclin-Dependent Kinase 4/6 Inhibitor (Palbociclib) Induced Aplastic Anemia in a Patient with Metastatic Breast Cancer. Case Rep Hematol. 2018; 2018:9249506.View Related Profiles. PMID: 30647983; PMCID: PMC6311830; DOI: 10.1155/2018/9249506;
     
  4. Edwards C, Sideeg A, Kunadu A, Sammut A, Redwood E. Adult- onset Still’s Disease. American College of Physicians Hospitalist Journal. 2016; 35-36.

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 4 publications over 4 distinct years, with a maximum of 1 publications in 2016 and 2018 and 2019 and 2021

YearPublications
20161
20181
20191
20211

Available to Mentor as: (Review Mentor Role Definitions):
  • Co-Mentor or Peer Mentor
  • Project Mentor
Contact for Mentoring:
  • Email (see 'Contact Info')
  • Phone (see 'Contact Info')

820 Harrison Ave
Boston MA 02118
Google Map


Edwards's Networks
Click the "See All" links for more information and interactive visualizations
Concepts
_
Co-Authors
_
Similar People
_
Same Department